Hansa Medical's 'Game Changer' In Transplantations May Have Other Uses Too

14 Feb 2018

• By Sten Stovall

Hansa Medical AB, a Swedish-listed, clinical-stage biotech, is focused on developing novel immunomodulatory enzymes for transplantation and acute autoimmune diseases that could change the face of kidney transplants.

Operation — Hansa Medical hopes its Ides comes to market by early 2020 in renal transplantation • Source: Shutterstock

Hansa Medical's 'Game Changer' In Transplantations May Have Other Uses Too

More from Clinical Trials

More from R&D